115 related articles for article (PubMed ID: 19906506)
1. Synthetic prostacycline agonist, ONO-1301, ameliorates left ventricular dysfunction and cardiac fibrosis in cardiomyopathic hamsters.
Hirata Y; Soeki T; Akaike M; Sakai Y; Igarashi T; Sata M
Biomed Pharmacother; 2009 Dec; 63(10):781-6. PubMed ID: 19906506
[TBL] [Abstract][Full Text] [Related]
2. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
Nakamura K; Sata M; Iwata H; Sakai Y; Hirata Y; Kugiyama K; Nagai R
Clin Sci (Lond); 2007 Jun; 112(12):607-16. PubMed ID: 17263691
[TBL] [Abstract][Full Text] [Related]
3. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
4. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
[TBL] [Abstract][Full Text] [Related]
5. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury.
Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M
Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of synthetic prostacycline agonist augments collateral growth and improves cardiac function in a swine chronic cardiac ischemia model.
Iwata H; Nakamura K; Sumi M; Ninomiya M; Sakai Y; Hirata Y; Akaike M; Igarashi T; Takamoto S; Nagai R; Sata M
Life Sci; 2009 Jul; 85(5-6):255-61. PubMed ID: 19527738
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model.
Hirata Y; Kurobe H; Uematsu E; Yagi S; Soeki T; Yamada H; Fukuda D; Shimabukuro M; Nakayama M; Matsumoto K; Sakai Y; Kitagawa T; Sata M
Eur J Pharmacol; 2013 Jan; 699(1-3):81-7. PubMed ID: 23219794
[TBL] [Abstract][Full Text] [Related]
8. Reorganization of cytoskeletal proteins and prolonged life expectancy caused by hepatocyte growth factor in a hamster model of late-phase dilated cardiomyopathy.
Kondoh H; Sawa Y; Fukushima N; Matsumiya G; Miyagawa S; Kitagawa-Sakakida S; Memon IA; Kawaguchi N; Matsuura N; Matsuda H
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):295-302. PubMed ID: 16077390
[TBL] [Abstract][Full Text] [Related]
9. Impact of cardiac support device combined with slow-release prostacyclin agonist in a canine ischemic cardiomyopathy model.
Kubota Y; Miyagawa S; Fukushima S; Saito A; Watabe H; Daimon T; Sakai Y; Akita T; Sawa Y
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1081-7. PubMed ID: 24131787
[TBL] [Abstract][Full Text] [Related]
10. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters.
Kondoh H; Sawa Y; Miyagawa S; Sakakida-Kitagawa S; Memon IA; Kawaguchi N; Matsuura N; Shimizu T; Okano T; Matsuda H
Cardiovasc Res; 2006 Feb; 69(2):466-75. PubMed ID: 16423569
[TBL] [Abstract][Full Text] [Related]
11. Defective activity and isoform of the Na,K-ATPase in the dilated cardiomyopathic hamster.
Paganelli F; Mougenot R; Maixentt JM
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):255-60. PubMed ID: 11354998
[TBL] [Abstract][Full Text] [Related]
12. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters.
Takai S; Jin D; Sakaguchi M; Katayama S; Muramatsu M; Sakaguchi M; Matsumura E; Kim S; Miyazaki M
J Pharmacol Exp Ther; 2003 Apr; 305(1):17-23. PubMed ID: 12649348
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.
Hayashi K; Kimata H; Obata K; Matsushita A; Fukata A; Hashimoto K; Noda A; Iwase M; Koike Y; Yokota M; Nagata K
J Card Fail; 2008 Apr; 14(3):238-44. PubMed ID: 18381188
[TBL] [Abstract][Full Text] [Related]
14. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
16. Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster.
Serose A; Prudhon B; Salmon A; Doyennette MA; Fiszman MY; Fromes Y
Basic Res Cardiol; 2005 Mar; 100(2):161-70. PubMed ID: 15611844
[TBL] [Abstract][Full Text] [Related]
17. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
18. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of 3 combinations of enalapril, metoprolol, and spironolactone on cardiac remodeling in dilated cardiomyopathic hamsters.
Laviolle B; Pape D; Turlin B; Bellissant E
J Card Fail; 2006 Dec; 12(9):752-8. PubMed ID: 17174238
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters.
Crespo MJ; Cruz N; Altieri PI; Escobales N
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):197-204. PubMed ID: 21149830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
